Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MIRA Bill Calls For One-Year Ceiling On National Coverage Decisions

This article was originally published in The Gray Sheet

Executive Summary

Pending Medicare coverage requests for positron emission tomography (PET) additional indications will need to be resolved rapidly if the "Medicare Innovation Responsiveness Act of 2003" is signed into law

You may also be interested in...



Ways & Means Drug Bill Provides Vehicle For MIRA Coverage, Coding Reforms

House lawmakers are still working to persuade hospital groups that new technology provisions included in the "Medicare Prescription & Modernization Act" of 2003 will not have a detrimental effect on hospital services

Ways & Means Drug Bill Provides Vehicle For MIRA Coverage, Coding Reforms

House lawmakers are still working to persuade hospital groups that new technology provisions included in the "Medicare Prescription & Modernization Act" of 2003 will not have a detrimental effect on hospital services

Tax Cuts, Rx Debate May Stymie Medicare Coverage Reforms – Rep. Cardin

Enacting tax cuts proposed by the Bush Administration could limit funding for Medicare reforms outside a prescription drug benefit, according to Rep. Ben Cardin (D-Md.)

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017976

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel